𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Comparative study between intravenous and subcutaneous administration of cladribine in treatment of hairy cell leukemia patients

✍ Scribed by Nehad M. Tawfik, Aml Soliman Nasr

Book ID
118788015
Publisher
Springer-Verlag
Year
2011
Tongue
English
Weight
165 KB
Volume
21
Category
Article
ISSN
1618-5641

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

The role of rituximab in combination wit
The role of rituximab in combination with pentostatin or cladribine for the treatment of recurrent/refractory hairy cell leukemia
✍ Monica Else; Nnenna Osuji; Francesco Forconi; Claire Dearden; Ilaria Del Giudice πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 97 KB

## Abstract ## BACKGROUND. The purine analogs pentostatin and cladribine have revolutionized the treatment of hairy cell leukemia (HCL) with overall responses in greater than 85% of patients and a median progression‐free survival of up to 15 years. They continue to be effective at second‐ and even

Deoxycoformycin in the treatment of pati
Deoxycoformycin in the treatment of patients with hairy cell leukemia : Results of a Spanish collaborative study of 80 patients
✍ Montserrat Rafel; Francisco Cervantes; JosΓ© MarΓ­a BeltrΓ‘n; Francisco Zuazu; Luis πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 81 KB πŸ‘ 2 views

## Background: Deoxycoformycin (dcf) has been reported to produce high response rates in patients with hairy cell leukemia (hcl), but to the authors' knowledge data regarding experience with such therapy in a large hcl series are scarce. ## Methods: Between 1988-1997, dcf (4 mg/m(2)/day, every 2